| # | Drug | Count |
|---|---|---|
| 0 | ADAPALENE | 610 |
| 1 | SALICYLIC ACID | 175 |
| 2 | DUPILUMAB | 124 |
| 3 | RIBOCICLIB | 65 |
| 4 | LETROZOLE | 62 |
| 5 | LETROZOLE TABLETS | 62 |
| 6 | TRIAMCINOLONE ACETONIDE | 60 |
| 7 | PREDNISONE | 49 |
| 8 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 44 |
| 9 | METHOTREXATE SODIUM | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | 14 | 0.0255 |
| 1 | PEMIVIBART | 1 | 0.0233 |
| 2 | METHOXSALEN | 2 | 0.0157 |
| 3 | MEDICATED HEMORRHOIDAL WIPES | 1 | 0.0115 |
| 4 | HALOBETASOL PROPIONATE AND TAZAROTENE | 2 | 0.0101 |
| 5 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 6 | MALATHION | 1 | 0.0099 |
| 7 | TALETRECTINIB | 1 | 0.0092 |
| 8 | CARBON DIOXIDE | 1 | 0.0087 |
| 9 | PEXIDARTINIB HYDROCHLORIDE | 6 | 0.0084 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 646 |
| 1 | Corticosteroid [EPC] | 170 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 124 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 90 |
| 4 | Aromatase Inhibitor [EPC] | 64 |
| 5 | Kinase Inhibitor [EPC] | 56 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 |
| 7 | Benzodiazepine [EPC] | 36 |
| 8 | Provitamin D2 Compound [EPC] | 36 |
| 9 | Vitamin C [EPC] | 36 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 2 | 0.0156 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 15 | 0.0132 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 5 | 0.0083 |
| 3 | Retinoid [EPC] | 646 | 0.0026 |
| 4 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 5 | Paramagnetic Contrast Agent [EPC] | 7 | 0.0015 |
| 6 | Aryl Hydrocarbon Receptor Agonist [EPC] | 3 | 0.0015 |
| 7 | Provitamin D2 Compound [EPC] | 36 | 0.0012 |
| 8 | Antiparasitic [EPC] | 5 | 0.0011 |
| 9 | Pediculicide [EPC] | 5 | 0.0011 |